Breaking News Instant updates and real-time market news.

AKBA

Akebia

$13.86

-0.25 (-1.77%)

17:07
07/14/17
07/14
17:07
07/14/17
17:07

Muneer A. Satter reports 6.48% stake in Akebia

AKBA Akebia
$13.86

-0.25 (-1.77%)

12/27/16
HCWC
12/27/16
NO CHANGE
Target $18
HCWC
Buy
Akebia deal with Otsuka tops expectations, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Akebia Therapeutics to $18 from $17 saying the company's collaboration with Otsuka Pharmaceutical exceeded his expectations. The analyst is surprised that the stock is up only 27% after four full trading days since the deal's announcement for a "modest" $86M gain in market cap. He notes that Akebia now has more than enough committed capital to fully fund the entire Phase 3 vadadustat development program. Arce keeps a Buy rating on Akebia.
03/07/17
UBSW
03/07/17
NO CHANGE
Target $12
UBSW
Buy
Akebia below fair value with readouts due in second half, says UBS
UBS analyst Jeffrey Hung noted Akebia provided an update to its development programs on their Q4 call and he believes the shares continue to trade below fair value. He acknowledged there is a lack of stock-moving catalysts at this time, but said the company is on track for data readouts in the second half of 2017. Hung reiterated his Buy rating and $12 price target on Akebia shares.
04/26/17
AGIS
04/26/17
NO CHANGE
Target $25
AGIS
Buy
Aegis says Akebia's expanded deal with Otsuka could lead to a takeout
Aegis analyst Difei Yang said Aekbia's expanded collaboration agreement with Otsuka for vadadustat is valued at $865M, comprising a $73M upfront fee, at least $135M in further development funding, and up to $657M in milestone payments. The analyst said the deal is positive for Akebia as it expands its collaboration with Otsuka and removes a financial overhang. Yang also sees the potential for Buy rated Akebia to be acquired by Otsuka after a positive Phase III readout and raised his price target on shares to $25 from $21.
05/16/17
NEED
05/16/17
NO CHANGE
Target $21
NEED
Buy
Akebia price target raised to $21 from $18 at Needham
Needham analyst Chad Messer raised his price target for Akebia Therapeutics to $21 after the company entered into a license agreement to sell vadadustat to Fresenius Medical Care dialysis clinics in the U.S. The deal is a positive for both the future commercial opportunity and the immediate funding needs at Akebia, Messer tells investors in a research note. He reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

01:45
08/14/18
08/14
01:45
08/14/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

BCE

BCE

$40.57

0.045 (0.11%)

21:57
08/13/18
08/13
21:57
08/13/18
21:57
Upgrade
BCE rating change at Edward Jones »

BCE upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$13.96

-0.11 (-0.78%)

21:55
08/13/18
08/13
21:55
08/13/18
21:55
Downgrade
Switch rating change at Raymond James »

Switch downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

FDC

First Data

$23.90

-0.78 (-3.16%)

21:55
08/13/18
08/13
21:55
08/13/18
21:55
Syndicate
First Data 64M share Secondary priced at $23.75 »

Citi acted as lead book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 14

    Aug

ARDS

Aridis Pharmaceuticals

$0.00

(0.00%)

21:54
08/13/18
08/13
21:54
08/13/18
21:54
Syndicate
Aridis Pharmaceuticals 2M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

JPM

JPMorgan

$113.88

-1.8 (-1.56%)

20:52
08/13/18
08/13
20:52
08/13/18
20:52
Periodicals
JPMorgan to stop offering investment accounts to foreign clients, Bloomberg says »

JPMorgan will discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

BIIB

Biogen

$340.67

-2.54 (-0.74%)

20:47
08/13/18
08/13
20:47
08/13/18
20:47
Periodicals
UK's NICE: Biogen's Spinraza too expensive for health service, Reuters reports »

U.K.'s National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

HD

Home Depot

$194.11

-2.19 (-1.12%)

, TPR

Tapestry

$47.42

-0.52 (-1.08%)

20:25
08/13/18
08/13
20:25
08/13/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

HD

Home Depot

$194.11

-2.19 (-1.12%)

TPR

Tapestry

$47.42

-0.52 (-1.08%)

AAP

Advance Auto Parts

$144.79

-1.52 (-1.04%)

EAT

Brinker

$43.81

-0.37 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 12

    Sep

HIL

Hill International

$5.65

(0.00%)

19:45
08/13/18
08/13
19:45
08/13/18
19:45
Hot Stocks
Hill International provides update on NYSE notice of delisting »

Hill Internationa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NVDA

Nvidia

$256.08

1.38 (0.54%)

19:36
08/13/18
08/13
19:36
08/13/18
19:36
Hot Stocks
Nvidia launches Turing GPU architecture in computer graphics »

NVIDIA today reinvented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ESRX

Express Scripts

$84.04

0.39 (0.47%)

, CI

Cigna

$181.78

-1.59 (-0.87%)

19:33
08/13/18
08/13
19:33
08/13/18
19:33
Hot Stocks
Carl Icahn says will no longer vote against Cigna/Express Scripts deal »

Today Carl Icahn released…

ESRX

Express Scripts

$84.04

0.39 (0.47%)

CI

Cigna

$181.78

-1.59 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 24

    Aug

  • 24

    Aug

MEOH

Methanex

$71.55

-0.45 (-0.63%)

19:17
08/13/18
08/13
19:17
08/13/18
19:17
Hot Stocks
Methanex signs natural gas supply agreement for Chile operations »

Methanex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$29.10

-0.03 (-0.10%)

19:16
08/13/18
08/13
19:16
08/13/18
19:16
Periodicals
Randa nearing decision on competing Perry Ellis bid, WWD reports »

Randa is in talks with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCBK

TriCo Bancshares

$39.20

-0.14 (-0.36%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Hot Stocks
TriCo Bancshares names Peter Wiese as CFO, effective August 14 »

TriCo Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 07

    Nov

ARQL

ArQule

$5.67

0.21 (3.85%)

, YEXT

Yext

$22.57

-0.18 (-0.79%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: ArQule (ARQL) up…

ARQL

ArQule

$5.67

0.21 (3.85%)

YEXT

Yext

$22.57

-0.18 (-0.79%)

CWT

California Water Service

$40.05

-0.4 (-0.99%)

SJW

SJW Corp.

$62.49

0.74 (1.20%)

VERI

Veritone

$15.81

1.05 (7.11%)

SWCH

Switch

$13.96

-0.11 (-0.78%)

VIPS

Vipshop

$8.98

-0.15 (-1.64%)

SAIL

SailPoint

$28.39

-0.43 (-1.49%)

RH

RH

$151.63

7.175 (4.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 13

    Aug

  • 14

    Aug

  • 04

    Sep

  • 04

    Sep

  • 10

    Sep

  • 16

    Aug

ROSE

Rosehill Resources

$8.36

-0.09 (-1.07%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Earnings
Rosehill Resources reports Q2 net income $8.7M vs. loss ($1.4M) last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

CMC

Commercial Metals

$21.80

0.11 (0.51%)

18:49
08/13/18
08/13
18:49
08/13/18
18:49
Upgrade
Commercial Metals rating change at Goldman Sachs »

Commercial Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

KALU

Kaiser Aluminum

$109.76

-1.35 (-1.22%)

18:44
08/13/18
08/13
18:44
08/13/18
18:44
Downgrade
Kaiser Aluminum rating change at Goldman Sachs »

Kaiser Aluminum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTA

Establishment Labs

$27.10

0.66 (2.50%)

18:09
08/13/18
08/13
18:09
08/13/18
18:09
Initiation
Establishment Labs initiated at BTIG »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

BRK.A

Berkshire Hathaway

$310,200.00

-1950 (-0.62%)

, BRK.B

Berkshire Hathaway

$205.17

-1.365 (-0.66%)

18:08
08/13/18
08/13
18:08
08/13/18
18:08
Hot Stocks
Berkshire Hathaway comments on quarterly reporting on Form 13F »

"Tomorrow afternoon,…

BRK.A

Berkshire Hathaway

$310,200.00

-1950 (-0.62%)

BRK.B

Berkshire Hathaway

$205.17

-1.365 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRO

Pros Holdings

$39.80

-0.2 (-0.50%)

18:06
08/13/18
08/13
18:06
08/13/18
18:06
Syndicate
PROS Holdings 450K share Block Trade; price range $7.60-$7.80 »

Barclays is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 14

    Aug

  • 20

    Aug

  • 21

    Aug

  • 16

    Aug

YY

YY

$87.72

-1.09 (-1.23%)

18:06
08/13/18
08/13
18:06
08/13/18
18:06
Earnings
Breaking Earnings news story on YY »

YY sees Q3 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 10

    Sep

ICUI

ICU Medical

$293.00

0.85 (0.29%)

18:05
08/13/18
08/13
18:05
08/13/18
18:05
Syndicate
ICU Medical 700K share Block Trade; price range $287-$290 »

Barclays is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

YY

YY

$87.72

-1.09 (-1.23%)

18:05
08/13/18
08/13
18:05
08/13/18
18:05
Earnings
YY reports Q2 adjusted EPS $2.03, consensus $1.77 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 10

    Sep

LAC

Lithium Americas

$3.56

-0.17 (-4.56%)

, SQM

SQM

$45.68

-1.16 (-2.48%)

18:03
08/13/18
08/13
18:03
08/13/18
18:03
Hot Stocks
Lithium Americas to partner with Ganfeng Lithium in Cauchari-Olaroz »

Lithium Americas (LAC) is…

LAC

Lithium Americas

$3.56

-0.17 (-4.56%)

SQM

SQM

$45.68

-1.16 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.